Lilly Rebates Prompt U.S. Attorney Investigation
This article was originally published in The Pink Sheet Daily
Executive SummaryThe Philadelphia U.S. Attorney’s office is investigating Medicaid best price reporting for Zyprexa and several other Lilly products.
You may also be interested in...
Allergan has tried to go after alopecia in the past; Exicure brings a new spherical nucleic acid (SNA) technology. In other recent deals, AstraZeneca sells Seroquel, Losec rights to Germany’s Cheplapharm.